These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 29175872

  • 1. Notch pathway inhibition targets chemoresistant insulinoma cancer stem cells.
    Capodanno Y, Buishand FO, Pang LY, Kirpensteijn J, Mol JA, Argyle DJ.
    Endocr Relat Cancer; 2018 Feb; 25(2):131-144. PubMed ID: 29175872
    [Abstract] [Full Text] [Related]

  • 2. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J, Tsujii M, Kondo J, Hayashi Y, Kato M, Akasaka T, Inoue T, Shiraishi E, Inoue T, Hiyama S, Tsujii Y, Maekawa A, Kawai S, Fujinaga T, Araki M, Shinzaki S, Watabe K, Nishida T, Iijima H, Takehara T.
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of NOTCH signaling pathway chemosensitizes HCC CD133+ cells to vincristine and 5-fluorouracil through upregulation of BBC3.
    Hemati H, Kaur J, Sobti RC, Trehanpati N.
    Biochem Biophys Res Commun; 2020 May 14; 525(4):941-947. PubMed ID: 32173531
    [Abstract] [Full Text] [Related]

  • 4. Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation.
    Nayak A, Das S, Nayak D, Sethy C, Narayan S, Kundu CN.
    Cell Oncol (Dordr); 2019 Apr 14; 42(2):157-171. PubMed ID: 30603978
    [Abstract] [Full Text] [Related]

  • 5. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
    Liu J, Mao Z, Huang J, Xie S, Liu T, Mao Z.
    Biochem Biophys Res Commun; 2014 Feb 21; 444(4):670-5. PubMed ID: 24502949
    [Abstract] [Full Text] [Related]

  • 6. Targeting Notch signaling by γ-secretase inhibitor I enhances the cytotoxic effect of 5-FU in gastric cancer.
    Lee HW, Kim SJ, Choi IJ, Song J, Chun KH.
    Clin Exp Metastasis; 2015 Aug 21; 32(6):593-603. PubMed ID: 26134677
    [Abstract] [Full Text] [Related]

  • 7. The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer.
    Abel EV, Kim EJ, Wu J, Hynes M, Bednar F, Proctor E, Wang L, Dziubinski ML, Simeone DM.
    PLoS One; 2014 Aug 21; 9(3):e91983. PubMed ID: 24647545
    [Abstract] [Full Text] [Related]

  • 8. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.
    Ponnurangam S, Dandawate PR, Dhar A, Tawfik OW, Parab RR, Mishra PD, Ranadive P, Sharma R, Mahajan G, Umar S, Weir SJ, Sugumar A, Jensen RA, Padhye SB, Balakrishnan A, Anant S, Subramaniam D.
    Oncotarget; 2016 Jan 19; 7(3):3217-32. PubMed ID: 26673007
    [Abstract] [Full Text] [Related]

  • 9. Proteomic analysis reveals that CD147/EMMPRIN confers chemoresistance in cancer stem cell-like cells.
    Kang MJ, Kim HP, Lee KS, Yoo YD, Kwon YT, Kim KM, Kim TY, Yi EC.
    Proteomics; 2013 May 19; 13(10-11):1714-25. PubMed ID: 23554123
    [Abstract] [Full Text] [Related]

  • 10. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.
    Huang R, Wang G, Song Y, Tang Q, You Q, Liu Z, Chen Y, Zhang Q, Li J, Muhammand S, Wang X.
    Mol Med Rep; 2015 Aug 19; 12(2):2417-24. PubMed ID: 25936357
    [Abstract] [Full Text] [Related]

  • 11. Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 (cyclooxygenase 2) and NOTCH/HES1 and activating PPARG in colorectal cancer.
    Moon CM, Kwon JH, Kim JS, Oh SH, Jin Lee K, Park JJ, Pil Hong S, Cheon JH, Kim TI, Kim WH.
    Int J Cancer; 2014 Feb 01; 134(3):519-29. PubMed ID: 23852449
    [Abstract] [Full Text] [Related]

  • 12. Notch2 signal is required for the maintenance of canine hemangiosarcoma cancer stem cell-like cells.
    Aoshima K, Fukui Y, Gulay KCM, Erdemsurakh O, Morita A, Kobayashi A, Kimura T.
    BMC Vet Res; 2018 Oct 03; 14(1):301. PubMed ID: 30285832
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling.
    Jin Y, Wang M, Hu H, Huang Q, Chen Y, Wang G.
    Int J Biol Macromol; 2018 Oct 01; 117():445-453. PubMed ID: 29852230
    [Abstract] [Full Text] [Related]

  • 17. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.
    Wang Z, Ahmad A, Li Y, Azmi AS, Miele L, Sarkar FH.
    Anticancer Res; 2011 Apr 01; 31(4):1105-13. PubMed ID: 21508353
    [Abstract] [Full Text] [Related]

  • 18. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties.
    Aoki S, Mizuma M, Takahashi Y, Haji Y, Okada R, Abe T, Karasawa H, Tamai K, Okada T, Morikawa T, Hayashi H, Nakagawa K, Motoi F, Naitoh T, Katayose Y, Unno M.
    BMC Cancer; 2016 Nov 07; 16(1):854. PubMed ID: 27821106
    [Abstract] [Full Text] [Related]

  • 19. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W, Gao Z, Duan Y, Yuan W, Ke Y.
    J Exp Clin Cancer Res; 2017 Mar 09; 36(1):41. PubMed ID: 28279221
    [Abstract] [Full Text] [Related]

  • 20. Significance of Notch and Wnt signaling for chemoresistance of colorectal cancer cells HCT116.
    Kukcinaviciute E, Jonusiene V, Sasnauskiene A, Dabkeviciene D, Eidenaite E, Laurinavicius A.
    J Cell Biochem; 2018 Jul 09; 119(7):5913-5920. PubMed ID: 29637602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.